- Home
- GNS vs ABVC Comparison
GNS vs ABVC Comparison
Compare GNS & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNS
- ABVC
- Stock Information
- Founded
- GNS 2002
- ABVC 2015
- Country
- GNS Singapore
- ABVC United States
- Employees
- GNS N/A
- ABVC N/A
- Industry
- GNS Other Consumer Services
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- GNS Real Estate
- ABVC Health Care
- Exchange
- GNS Nasdaq
- ABVC Nasdaq
- Market Cap
- GNS 17.8M
- ABVC 16.7M
- IPO Year
- GNS 2022
- ABVC N/A
- Fundamental
- Price
- GNS $0.33
- ABVC $0.88
- Analyst Decision
- GNS
- ABVC
- Analyst Count
- GNS 0
- ABVC 0
- Target Price
- GNS N/A
- ABVC N/A
- AVG Volume (30 Days)
- GNS 1.9M
- ABVC 648.3K
- Earning Date
- GNS 05-14-2025
- ABVC 04-15-2025
- Dividend Yield
- GNS N/A
- ABVC N/A
- EPS Growth
- GNS N/A
- ABVC N/A
- EPS
- GNS N/A
- ABVC N/A
- Revenue
- GNS $16,147,348.00
- ABVC $509,588.00
- Revenue This Year
- GNS N/A
- ABVC $735.18
- Revenue Next Year
- GNS $47.43
- ABVC N/A
- P/E Ratio
- GNS N/A
- ABVC N/A
- Revenue Growth
- GNS N/A
- ABVC 234.31
- 52 Week Low
- GNS $0.21
- ABVC $0.40
- 52 Week High
- GNS $5.69
- ABVC $1.73
- Technical
- Relative Strength Index (RSI)
- GNS 57.76
- ABVC 51.34
- Support Level
- GNS $0.26
- ABVC $0.82
- Resistance Level
- GNS $0.26
- ABVC $1.00
- Average True Range (ATR)
- GNS 0.03
- ABVC 0.17
- MACD
- GNS 0.01
- ABVC -0.02
- Stochastic Oscillator
- GNS 95.74
- ABVC 23.31
About GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education - entrepreneur education, management consultancy, and business development tools; and Campus - resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.